PubMed:1823613 / 0-283 JSONTXT

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":147,"end":160},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":212,"end":217},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G58507AZ"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G17108EX"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00047MO"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":92},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":92},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":147,"end":160},"obj":"https://glytoucan.org/Structures/Glycans/G17108EX"},{"id":"T2","span":{"begin":147,"end":160},"obj":"https://glytoucan.org/Structures/Glycans/G58507AZ"},{"id":"T3","span":{"begin":212,"end":217},"obj":"https://glytoucan.org/Structures/Glycans/G00047MO"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":147,"end":152},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T2","span":{"begin":147,"end":152},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"T3","span":{"begin":200,"end":205},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T4","span":{"begin":200,"end":205},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":147,"end":160},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G00066MO"},{"id":"A3","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G00066MO"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":92},"obj":"Sentence"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":147,"end":152},"obj":"Body_part"},{"id":"T2","span":{"begin":200,"end":205},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"GlyCosmos15-FMA","denotations":[{"id":"T1","span":{"begin":147,"end":152},"obj":"Body_part"},{"id":"T2","span":{"begin":200,"end":205},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"FMA:9670"},{"id":"A2","pred":"db_id","subj":"T2","obj":"FMA:9670"}],"namespaces":[{"prefix":"FMA","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T1","span":{"begin":147,"end":152},"obj":"Body_part"},{"id":"T2","span":{"begin":200,"end":205},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A2","pred":"mat_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":147,"end":152},"obj":"Body_part"},{"id":"T3","span":{"begin":200,"end":205},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A4","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":147,"end":152},"obj":"Body_part"},{"id":"T2","span":{"begin":200,"end":205},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.\nA bifunctional hapten was synthesized consisting of a blood group A active tetrasaccharide (A-tetra) and a blood group Le(a) active pentasaccharide lacto-N-fucopentaose II (LNF II), linked t"}